ANACOR PHARMACEUTICALS INC COM
ANAC
ANAC was delisted on the 23rd of June, 2016.
87 hedge funds and large institutions have $535M invested in ANACOR PHARMACEUTICALS INC COM in 2013 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 23 increasing their positions, 32 reducing their positions, and 12 closing their positions.
150% more funds holding in top 10
Funds holding in top 10: 2 → 5 (+3)
75% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 12
66% more capital invested
Capital invested by funds: $321M → $535M (+$213M)
25% more call options, than puts
Call options by funds: $362K | Put options by funds: $289K
12% more funds holding
Funds holding: 78 → 87 (+9)
28% less repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 32
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baker Bros. Advisors
New York
|
+$22.5M |
| 2 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$14.6M |
| 3 |
CCM
Consonance Capital Management
New York
|
+$8.75M |
| 4 |
State Street
Boston,
Massachusetts
|
+$6.84M |
| 5 |
Jennison Associates
New York
|
+$5.31M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCP
Rho Capital Partners
New York
|
-$21.5M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$15M |
| 3 |
PA
Perceptive Advisors
New York
|
-$6.73M |
| 4 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
-$3.47M |
| 5 |
BC
Broadfin Capital
New York
|
-$3.05M |
ANAC Hedge Fund Activity: Q4 2013 in Review
87 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in ANACOR PHARMACEUTICALS INC COM (ANAC) for Q4 2013, worth a combined $535M — up 66% from $321M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new ANAC positions and 12 closed out — a net gain of 9 holders — while 23 added to existing stakes and 32 trimmed.
The largest buyer was Baker Bros. Advisors, adding an estimated $22.5M. The largest seller was Rho Capital Partners, cutting an estimated $21.5M.
- 87 institutional investors held ANACOR PHARMACEUTICALS INC COM (ANAC) as of Q4 2013, up from 78 in Q3 2013.
- Funds reported $535M of ANACOR PHARMACEUTICALS INC COM stock for Q4 2013, up 66% quarter-over-quarter.
- 21 funds opened new ANACOR PHARMACEUTICALS INC COM positions in Q4 2013 and 12 closed out, a net change of +9 holders.
- The largest ANACOR PHARMACEUTICALS INC COM buyer in Q4 2013 was Baker Bros. Advisors, an estimated $22.5M added.
- The largest ANACOR PHARMACEUTICALS INC COM seller in Q4 2013 was Rho Capital Partners, an estimated $21.5M sold.
Based on aggregated 13F filings for Q4 2013.